Thursday, October 27, 2016 12:55:11 PM
that there is no reason to give credence to what I say. Nevertheless, I will simply share my thinking and you and others are free to do with it whatever they wish.
A draft of the CEO has been written. When or if it will be published is another matter. Based on conversations I've had with other interested parties, none of whom are employed by NNVC, indicate there is considerable dissension in the ranks. While the disgruntled had been comprised exclusively of shareholders outside the company, that is no longer the case. One of the prime points of disagreement is the issue of transparency.
Just think about it from a logical perspective - if you were inside the company, either in the capacity of an officer or a member of the BOD wouldn't you be uncomfortable with claims that are at odds with the facts? While I don't believe there has been fraud, at a certain point lack of candor transitions into lying. Most people don't like doing that. One can only hide from the truth for so long, unless one is delusional. Most people are not delusional and they want to feel good about what they are doing. I firmly believe that and my belief is support by the bulk of psychological studies that have looked into the matter. (Ekman)
When a CEO letter comes, if it does, I will let the market's reaction be the judge. For the moment the stock is still in technical limbo. Liquidity and trading volume have dried up as the stock flirts with a key support zone.
Trendliner
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM